| |
 |
|
Class Information
Number: 424/185.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same
Description: Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7622122 |
Methods of using novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
Nov. 24, 2009 |
| 7622120 |
Peptide originating from vaccinia virus |
Nov. 24, 2009 |
| 7622119 |
Cancer antigen peptides derived from WT1 |
Nov. 24, 2009 |
| 7622105 |
Modified cytokines for use in cancer therapy |
Nov. 24, 2009 |
| 7618936 |
Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1) |
Nov. 17, 2009 |
| 7618636 |
Antigenic meningococcal peptides |
Nov. 17, 2009 |
| 7618635 |
Super-antigen fusion proteins and the use thereof |
Nov. 17, 2009 |
| 7618634 |
Neurotoxic oligomers |
Nov. 17, 2009 |
| 7615229 |
Mutants of the P4 protein of nontypable Haemophilus influenzae with reduced enzymatic activity |
Nov. 10, 2009 |
| 7612175 |
Scavenger receptor |
Nov. 3, 2009 |
| 7612174 |
Scavenger receptor |
Nov. 3, 2009 |
| 7612168 |
Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
Nov. 3, 2009 |
| 7612038 |
Biglycan and related therapeutics and methods of use |
Nov. 3, 2009 |
| 7611720 |
Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
Nov. 3, 2009 |
| 7611719 |
Enterovirus, vaccines, medicaments and diagnostic kits |
Nov. 3, 2009 |
| 7611711 |
VEGFR-3 inhibitor materials and methods |
Nov. 3, 2009 |
| 7608683 |
Stress proteins and peptides and methods of use thereof |
Oct. 27, 2009 |
| 7608277 |
Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
Oct. 27, 2009 |
| 7608269 |
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
Oct. 27, 2009 |
| 7608268 |
Ferritin fusion proteins for use in vaccines and other applications |
Oct. 27, 2009 |
| 7608266 |
Yersinia species compositions |
Oct. 27, 2009 |
| 7608256 |
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
Oct. 27, 2009 |
| 7601814 |
Reducing the immunogenicity of fusion proteins |
Oct. 13, 2009 |
| 7601358 |
Mycobacterium tuberculosis protein composition |
Oct. 13, 2009 |
| 7601357 |
Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
Oct. 13, 2009 |
| 7598223 |
Methods for producing target cell reactive lymphocytes |
Oct. 6, 2009 |
| 7597896 |
Composition comprising a protein encoded by a modified ERP gene of Mycobacterium |
Oct. 6, 2009 |
| 7597894 |
Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
Oct. 6, 2009 |
| 7595383 |
Secreted proteins of Mycobacterium tuberculosis and their use as vaccines and diagnostic reagents |
Sep. 29, 2009 |
| 7595058 |
Chlamydia antigens and vaccine uses of the protein |
Sep. 29, 2009 |
| 7595057 |
Streptococcus pyogenes antigens and corresponding DNA fragments |
Sep. 29, 2009 |
| 7595052 |
Composition and method for the prevention and/or the treatment of allergy |
Sep. 29, 2009 |
| 7592425 |
Cytokine zalpha11 ligand fusion proteins |
Sep. 22, 2009 |
| 7592421 |
HLA class II peptide mimics |
Sep. 22, 2009 |
| 7592310 |
Induction of antibiotic proteins and peptides by LAIT/sCD14-protein |
Sep. 22, 2009 |
| 7592010 |
Albumin fusion proteins |
Sep. 22, 2009 |
| 7592009 |
Polypeptide ligands for targeting cartilage and methods of use thereof |
Sep. 22, 2009 |
| 7592008 |
Membrane scaffold proteins |
Sep. 22, 2009 |
| 7591997 |
Method for determining the susceptibility of a subject to infection |
Sep. 22, 2009 |
| 7589177 |
Nucleic acid molecules encoding cyclotide polypeptides and methods of use |
Sep. 15, 2009 |
| 7589172 |
PRO256 polypeptides |
Sep. 15, 2009 |
| 7588930 |
Compositions and methods for enhancing the immunogenicity of antigens |
Sep. 15, 2009 |
| 7588763 |
Methods for the prevention against or treatment of diabetes with ETXB and/or insulin |
Sep. 15, 2009 |
| 7585509 |
Erb-2 receptor targeting peptide |
Sep. 8, 2009 |
| 7582735 |
Feline immunoglobulin E molecules and related methods |
Sep. 1, 2009 |
| 7582726 |
VEGF receptor antagonists |
Sep. 1, 2009 |
| 7582603 |
Method for treating or inhibiting intestinal inflammation |
Sep. 1, 2009 |
| 7582304 |
Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans |
Sep. 1, 2009 |
| 7579441 |
Cytokine zalpha11 ligand fusion proteins |
Aug. 25, 2009 |
| 7579141 |
Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
Aug. 25, 2009 |
|
|
|
